The knowledge and paradigms generated by our research project will not only drive major technological advances in tissue-engineering and bioprinting but will also open radically new possibilities in medicine

 
E12.5-Pancreas-&-gut_embryos_Ecad-594_sox17-488_Confocal.jpg
 

ABOUT THE PROJECT

The EU H2020 FET-Open Pan3DP project establishes a multi-disciplinary consortium with the goal of developing an innovative bioprinting approach for generating pancreatic tissue. Tissues and organs comprise multiple cell types with specific biological functions that must be recapitulated in the printed tissue.

We will biomimic developmental processes to fabricate 3D bioprinted pancreatic tissue units that allow sustained cell viability, expansion and functional differentiation ex vivo.

The knowledge and paradigms generated by our research project will not only drive major technological advances in tissue-engineering and bioprinting but will also open radically new possibilities in medicine, allowing to study pancreatic diseases ex vivo in fabricated tissue, to develop new drugs, and, possibly to facilitate the replacement of injured or diseased tissue.

 

OUR Project team:

Francesca M. Spagnoli (KCL) - King’s College London, United Kingdom

Limor Landsman (TAU) - Tel Aviv University, Tel Aviv, Israel

Christophe Pierreux (DDI) - de Duve Institute-UCL, Brussels, Belgium

Dagmar Iber (ETH) - ETH, Basel, Switzerland

Shulamit Levenberg (TEC) - Technion Israel Institute of Technology, Haifa, Israel

Fabien Guillemot, Poietis (POI) - Bioparc Bordeaux Métropole, France